乳腺癌的预后指标是一个传统的研究课题。
Studying prognostic factors of breast cancer is a traditional subject.
结论：HER - 2可作为乳腺癌患者预后判断的指标。
Conclusion: HER-2 can serve as markers for prognosis judgment of breast cancer patients.
原发性乳腺癌组织中的MVD及VEGF表达与肿瘤的转移行为密切相关，有可能作为判定肿瘤生物学行为、转移潜能及预后的指标。
MVD and the expression of VEGF are highly correlated with metastasis in primary breast cancer, which may serve as a parameter for determining tumor biological, metastatic potential and prognosis.
研究还发现FAS在肺癌和前列腺癌中高表达，FAS的表达是乳腺癌和前列腺癌预后不良的指标(3 - 5)。
Studies also showed that FAS is highly expressed in lung and prostate cancers and that FAS expression is an indicator of poor prognosis in breast and prostate cancer (3-5).
乳腺癌细胞核形态参数和DNA含量可作为乳腺癌诊断、预后判定的指标之一。
The DNA content and nucleus morphometry may be regarded as one of the useful indicators for the pathological diagnosis and clinical prognosis of breast carcinoma.
本文综述了乳腺癌的分子预后指标，它们与乳腺癌的恶性转化及预后有关。
The indices of molecule for prognosis of the breast cancer are reviewed in this paper. They have relevance to malignant transformation and prognosis of breast cancer.
结论：EMS1基因可能是乳腺癌的一种新预后指标。
Conclusion: EMS1 gene may be a new prognosis factor of breast cancer.
因此人t可作为乳腺癌有价值的预后预测指标。
Thus AT maybe has potential prognostic value for breast carcinoma.
结论CA12 5、CA15 - 3对乳腺癌有一定的诊断价值，且可作为监测乳腺癌病情进展、评估预后的指标。
Conclusion CA125 and CA15-3 are helpful to diagnose breast cancer, and can serve as a biological marker for monitoring tumor progression and evaluating prognosis in breast cancer.
结论CA12 5、CA15 - 3对乳腺癌有一定的诊断价值，且可作为监测乳腺癌病情进展、评估预后的指标。
Conclusion CA125 and CA15-3 are helpful to diagnose breast cancer, and can serve as a biological marker for monitoring tumor progression and evaluating prognosis in breast cancer.
应用推荐